Leadership Overview
Macleods Pharmaceuticals has 7 executives leading key functions including operations, financial strategy, tender business, corporate governance, engineering services, and executive management.
Focused on delivering high-quality generic medications globally, Macleods Pharmaceuticals maintains a commitment to manufacturing excellence and affordable healthcare solutions across diverse international markets.
Focused on delivering high-quality generic medications globally, Macleods Pharmaceuticals maintains a commitment to manufacturing excellence and affordable healthcare solutions across diverse international markets.
Leadership Roles at Macleods Pharmaceuticals
Ashok Prasad - Chief Financial Officer
Ashok Prasad, the Chief Financial Officer at Macleods Pharmaceuticals, manages the fiscal health and capital allocation strategies of the organization. Overseeing financial reporting and budgetary controls, the Chief Financial Officer ensures alignment with long-term corporate objectives. This leadership role involves analyzing market trends to guide investment in new pharmaceutical manufacturing capabilities. By maintaining robust financial oversight, Ashok Prasad directly supports the expansion of the product portfolio. The Chief Financial Officer collaborates with the board to mitigate economic risks while maximizing shareholder value. Through disciplined management of assets and liabilities, Prasad secures the financial stability required for ongoing research and development. This position demands precise forecasting to navigate the complexities of the global generic drug market. Ultimately, Prasad architects the financial framework that enables the company to deliver affordable healthcare solutions on a massive scale.
Manoranjan Prasad - Chief Financial Officer & Head of Tender Business
Manoranjan Prasad, the Chief Financial Officer & Head of Tender Business at Macleods Pharmaceuticals, directs the strategic acquisition of government and institutional contracts. Overseeing the tender bidding process, the Chief Financial Officer & Head of Tender Business ensures competitive positioning within public health sectors. This leadership role involves evaluating the profitability of large-scale drug supply agreements. By managing the financial aspects of tender submissions, Manoranjan Prasad directly influences the market reach of the company. The Chief Financial Officer & Head of Tender Business coordinates with sales teams to secure high-volume orders across diverse geographic regions. Through rigorous analysis of contract requirements, Prasad optimizes the revenue streams derived from institutional partnerships. This position requires balancing aggressive bidding strategies with strict fiscal discipline to ensure sustainable margins. Ultimately, Prasad drives the growth of the tender business unit through expert financial and commercial oversight.
Abhishek Sanghavi - Chief Operating Officer
Abhishek Sanghavi, the Chief Operating Officer at Macleods Pharmaceuticals, directs all manufacturing workflows and supply chain logistics. Overseeing production facilities across India, the Chief Operating Officer ensures consistent output of tablets, syrups, and essential drugs. This leadership role involves optimizing factory efficiency to meet rigorous global quality standards. By streamlining internal processes, Abhishek Sanghavi directly impacts the ability of the company to scale production for international markets. The Chief Operating Officer coordinates with engineering teams to maintain state-of-the-art equipment, ensuring uninterrupted pharmaceutical supply. Through meticulous oversight of daily operations, Sanghavi secures the operational foundation necessary for sustained growth. This position requires constant monitoring of manufacturing metrics to uphold the reputation of the firm as a reliable provider of generic pharmaceuticals. Ultimately, Sanghavi drives the operational excellence that defines the market presence of the organization.
Bhumi Patil - Secretary & President
Bhumi Patil, the Secretary & President at Macleods Pharmaceuticals, governs corporate compliance and executive administration. Overseeing regulatory adherence and board communications, the Secretary & President ensures the organization operates within legal frameworks. This leadership role involves managing corporate records and facilitating high-level decision-making processes. By maintaining strict governance standards, Bhumi Patil directly protects the integrity of the company. The Secretary & President coordinates with legal counsel to address international pharmaceutical regulations, ensuring seamless market access. Through proactive management of corporate affairs, Patil supports the strategic vision of the leadership team. This position requires deep knowledge of industry-specific legal requirements to mitigate operational risks. Ultimately, Patil architects the administrative infrastructure that allows the firm to function effectively as a global manufacturer of generic drugs, ensuring that all corporate activities align with the mission of providing accessible healthcare.
Ashish Mungantiwar - Executive President
Ashish Mungantiwar, the Executive President at Macleods Pharmaceuticals, directs high-level strategic initiatives and organizational development. Overseeing cross-functional teams, the Executive President ensures the execution of the corporate mission across all manufacturing divisions. This leadership role involves fostering innovation in drug development and production methodologies. By aligning departmental goals with the overarching business strategy, Ashish Mungantiwar directly impacts the competitive standing of the company. The Executive President collaborates with other senior leaders to identify new market opportunities for tablets and syrups. Through effective management of human capital and resources, Mungantiwar drives the internal culture toward excellence and efficiency. This position requires a comprehensive understanding of the pharmaceutical landscape to guide the firm through complex industry shifts. Ultimately, Mungantiwar secures the long-term success of the organization by championing strategic growth and maintaining a focus on high-quality pharmaceutical manufacturing.
Lalit Patro - President, Corporate Engineering Services
Lalit Patro, the President, Corporate Engineering Services at Macleods Pharmaceuticals, directs the design and maintenance of advanced manufacturing infrastructure. Overseeing the engineering department, the President, Corporate Engineering Services ensures that all production facilities utilize cutting-edge technology for drug synthesis. This leadership role involves managing capital projects to expand manufacturing capacity for tablets and syrups. By optimizing technical systems, Lalit Patro directly enhances the efficiency and safety of the production environment. The President, Corporate Engineering Services coordinates with operations teams to implement sustainable engineering solutions that reduce waste and energy consumption. Through rigorous oversight of facility upgrades, Patro ensures compliance with international manufacturing standards. This position requires constant innovation to keep the infrastructure aligned with the evolving needs of the pharmaceutical industry. Ultimately, Patro architects the technical foundation that enables the company to maintain its status as a leading manufacturer of generic medications.
Rajesh Kabu - President
Rajesh Kabu, the President at Macleods Pharmaceuticals, directs the overarching business strategy and market expansion efforts. Overseeing global commercial activities, the President ensures the successful distribution of generic pharmaceuticals to diverse international markets. This leadership role involves identifying emerging opportunities for product growth and strengthening relationships with key stakeholders. By driving the strategic vision, Rajesh Kabu directly influences the market impact of the company. The President coordinates with various department heads to ensure that manufacturing, finance, and engineering efforts remain synchronized with corporate goals. Through decisive leadership, Kabu navigates the complexities of the global drug industry to maintain a competitive edge. This position requires a focus on long-term sustainability and the continuous improvement of product quality. Ultimately, Kabu secures the future of the organization by fostering a culture of innovation and excellence in the delivery of affordable healthcare solutions.
Explore Leadership Teams in Manufacturing
SOHO Global Health is a pioneer in natural herbal-based medicine, focusing on innovative herbal research and the development of high-quality health products. Their product range includes immune boosters, children's multivitamins, and supplements aimed at improving overall health and wellness. The company is committed to harnessing Indonesia's natural resources and indigenous plants to enhance the health of its customers. SOHO Global Health aims to create positive societal impacts through strategic partnerships and a customer-centric approach.
Company Leadership RL

PB
Dexcel Pharma is Israel’s largest privately owned pharmaceutical company, founded in 1968 and headquartered in Or Akiva. It develops, manufactures, and commercializes value‑added branded prescription drugs, generics, and OTC products—primarily oral solid dosage forms—supplying more than 85 products in over 175 dosage forms to markets including the U.S., U.K., Germany, Austria, and others through subsidiaries and distribution partners.
Company Leadership DO


EH
Synokem Pharmaceuticals Ltd is a rising pharmaceutical organization established in 1983, specializing in contract manufacturing, ethical marketing, exports, and institutional supplies. The company aims to provide quality pharmaceutical products that are affordable to all sections of society, with a vision to become a world-class manufacturer. Synokem is committed to enhancing its market share through strategic alliances and collaborations, particularly in the international business sector. With a focus on research and development, the company is dedicated to achieving significant growth and establishing itself as an industry leader.
Company Leadership PS
SA
AK
RM
Madrigal Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) -selective agonist, which is in Phase II clinical trials for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia.
Company Leadership
RF
SK
CW